Up to $5.6M Awarded to Develop Novel Antibiotic
As part of our Infection Research Initiative, the Foundation awarded up to $5.6 million to Microbion Corp. to develop an inhaled antibiotic that could help break down biofilms and kill drug-resistant bacteria in people with cystic fibrosis. A biofilm is a community of bacteria that encloses itself in a protective layer, often enabling it to both evade the immune system and to become more resistant to antibiotics.
Read more »
| |
NACFC Will Be Virtual in 2020NACFC is a critical opportunity for cystic fibrosis clinicians and scientists to come together, collaborate, and share important findings that will drive continued progress in the fight against CF. With the safety of our community as a top priority, we have made the decision to offer NACFC as a virtual meeting this year.
We will be working with the NACFC Program Planning Committee to design the event and reimagine the experience over the coming months and will provide additional information in August when registration opens.
Learn more »
| |
Upcoming Virtual EventMark your calendars for CF FamilyCon on June 18 and 20! Adults with cystic fibrosis and their loved ones ages 16 and older are invited to this free, two-day, online event. Learn from others, connect virtually, and share stories unique to life with CF during keynotes, panels, group chats, fun activities, story hour, and small-group video breakouts.
Register today »
| |
CF Foundation Hosts Policy Briefing on Paid Leave
| |
Together: Celebrating 65 Years
The recording from last week’s virtual event, Together: Celebrating 65 Years, is now available. Hear from members of the cystic fibrosis community as we celebrate all we have achieved together over the last 65 years, and unite in our focus to achieve our mission.
Watch the recording »
| |
|
|
|
|
